Joanne Wuensch
Stock Analyst at Citigroup
(4.05)
# 419
Out of 5,182 analysts
470
Total ratings
58.44%
Success rate
9.2%
Average return
Main Sectors:
Stocks Rated by Joanne Wuensch
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| MDT Medtronic | Maintains: Buy | $117 → $110 | $82.92 | +32.66% | 23 | Apr 7, 2026 | |
| BSX Boston Scientific | Maintains: Buy | $94 → $87 | $59.95 | +45.12% | 38 | Apr 7, 2026 | |
| SYK Stryker | Maintains: Buy | $420 → $385 | $329.01 | +17.02% | 16 | Apr 7, 2026 | |
| PODD Insulet | Downgrades: Neutral | $338 → $230 | $188.31 | +22.14% | 19 | Apr 7, 2026 | |
| MMED MiniMed Group | Initiates: Buy | $23 | $12.92 | +78.02% | 1 | Mar 31, 2026 | |
| JNJ Johnson & Johnson | Maintains: Buy | $250 → $274 | $225.34 | +21.59% | 18 | Mar 11, 2026 | |
| IRTC iRhythm Holdings | Maintains: Buy | $242 → $214 | $125.96 | +69.90% | 23 | Mar 11, 2026 | |
| IART Integra LifeSciences Holdings | Maintains: Sell | $11 → $9 | $10.69 | -15.81% | 17 | Mar 11, 2026 | |
| HAE Haemonetics | Maintains: Neutral | $75 → $70 | $60.69 | +15.34% | 12 | Mar 11, 2026 | |
| GEHC GE HealthCare Technologies | Maintains: Neutral | $88 → $84 | $70.48 | +19.18% | 9 | Mar 11, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Neutral | $81 → $74 | $65.47 | +13.03% | 9 | Mar 11, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $77 → $84 | $61.41 | +36.79% | 18 | Mar 11, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Neutral | $21 → $19 | $18.49 | +2.76% | 23 | Mar 11, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $140 → $136 | $92.80 | +46.55% | 24 | Mar 11, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Upgrades: Buy | $590 | $470.99 | +25.27% | 20 | Mar 11, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Neutral | $9.1 → $6.5 | $4.32 | +50.46% | 15 | Mar 6, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Neutral | $88 → $87 | $64.34 | +35.22% | 23 | Mar 6, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Neutral | $75 → $92 | $85.45 | +7.67% | 10 | Feb 20, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $20 → $21 | $15.88 | +32.24% | 7 | Feb 19, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Neutral | $94 → $98 | $92.59 | +5.84% | 24 | Feb 11, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Neutral | $350 → $374 | $327.98 | +14.03% | 27 | Jan 16, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $113 → $125 | $121.77 | +2.66% | 23 | Dec 11, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $96 → $101 | $83.46 | +21.02% | 22 | Dec 11, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Neutral | $16 → $22 | $19.82 | +11.00% | 21 | Dec 11, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Neutral | $6.5 → $4.15 | $1.28 | +224.22% | 12 | May 22, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Upgrades: Neutral | $220 → $250 | $150.22 | +66.42% | 5 | Dec 12, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Neutral | $67 → $69 | $76.01 | -9.22% | 5 | Nov 17, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Upgrades: Outperform | $109 → $127 | $222.02 | -42.80% | 6 | Dec 10, 2018 |
Medtronic
Apr 7, 2026
Maintains: Buy
Price Target: $117 → $110
Current: $82.92
Upside: +32.66%
Boston Scientific
Apr 7, 2026
Maintains: Buy
Price Target: $94 → $87
Current: $59.95
Upside: +45.12%
Stryker
Apr 7, 2026
Maintains: Buy
Price Target: $420 → $385
Current: $329.01
Upside: +17.02%
Insulet
Apr 7, 2026
Downgrades: Neutral
Price Target: $338 → $230
Current: $188.31
Upside: +22.14%
MiniMed Group
Mar 31, 2026
Initiates: Buy
Price Target: $23
Current: $12.92
Upside: +78.02%
Johnson & Johnson
Mar 11, 2026
Maintains: Buy
Price Target: $250 → $274
Current: $225.34
Upside: +21.59%
iRhythm Holdings
Mar 11, 2026
Maintains: Buy
Price Target: $242 → $214
Current: $125.96
Upside: +69.90%
Integra LifeSciences Holdings
Mar 11, 2026
Maintains: Sell
Price Target: $11 → $9
Current: $10.69
Upside: -15.81%
Haemonetics
Mar 11, 2026
Maintains: Neutral
Price Target: $75 → $70
Current: $60.69
Upside: +15.34%
GE HealthCare Technologies
Mar 11, 2026
Maintains: Neutral
Price Target: $88 → $84
Current: $70.48
Upside: +19.18%
Mar 11, 2026
Maintains: Neutral
Price Target: $81 → $74
Current: $65.47
Upside: +13.03%
Mar 11, 2026
Maintains: Buy
Price Target: $77 → $84
Current: $61.41
Upside: +36.79%
Mar 11, 2026
Maintains: Neutral
Price Target: $21 → $19
Current: $18.49
Upside: +2.76%
Mar 11, 2026
Maintains: Buy
Price Target: $140 → $136
Current: $92.80
Upside: +46.55%
Mar 11, 2026
Upgrades: Buy
Price Target: $590
Current: $470.99
Upside: +25.27%
Mar 6, 2026
Maintains: Neutral
Price Target: $9.1 → $6.5
Current: $4.32
Upside: +50.46%
Mar 6, 2026
Maintains: Neutral
Price Target: $88 → $87
Current: $64.34
Upside: +35.22%
Feb 20, 2026
Maintains: Neutral
Price Target: $75 → $92
Current: $85.45
Upside: +7.67%
Feb 19, 2026
Maintains: Buy
Price Target: $20 → $21
Current: $15.88
Upside: +32.24%
Feb 11, 2026
Maintains: Neutral
Price Target: $94 → $98
Current: $92.59
Upside: +5.84%
Jan 16, 2026
Downgrades: Neutral
Price Target: $350 → $374
Current: $327.98
Upside: +14.03%
Dec 11, 2025
Maintains: Buy
Price Target: $113 → $125
Current: $121.77
Upside: +2.66%
Dec 11, 2025
Maintains: Buy
Price Target: $96 → $101
Current: $83.46
Upside: +21.02%
Dec 11, 2025
Maintains: Neutral
Price Target: $16 → $22
Current: $19.82
Upside: +11.00%
May 22, 2025
Maintains: Neutral
Price Target: $6.5 → $4.15
Current: $1.28
Upside: +224.22%
Dec 12, 2022
Upgrades: Neutral
Price Target: $220 → $250
Current: $150.22
Upside: +66.42%
Nov 17, 2022
Maintains: Neutral
Price Target: $67 → $69
Current: $76.01
Upside: -9.22%
Dec 10, 2018
Upgrades: Outperform
Price Target: $109 → $127
Current: $222.02
Upside: -42.80%